Ftse Mib
37.100,33
1,42%
DAX
21.902,42
1,63%
S&P 500
6.083,57
0,36%
NASDAQ
19.791,99
0,51%
Bitcoin
96.468,15
-0,16%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vera Therapeutics Inc (VERA) Vera Therapeutics Inc (VERA) Notizie

VERA

Vera Therapeutics (VERA)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VERA
DataOraFonteTitoloSimboloCompagnia
13/01/202514:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VERAVera Therapeutics Inc
10/01/202522:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VERAVera Therapeutics Inc
08/01/202522:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VERAVera Therapeutics Inc
20/11/202422:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VERAVera Therapeutics Inc
14/11/202422:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VERAVera Therapeutics Inc
07/11/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VERAVera Therapeutics Inc
30/10/202421:15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VERAVera Therapeutics Inc
28/10/202422:29Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:VERAVera Therapeutics Inc
11/04/202413:24IH Market NewsCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’ AI Chip, and More NewsNASDAQ:VERAVera Therapeutics Inc
14/02/202422:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VERAVera Therapeutics Inc
30/01/202403:58Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:VERAVera Therapeutics Inc
23/06/202322:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VERAVera Therapeutics Inc
22/06/202322:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VERAVera Therapeutics Inc
20/06/202313:51Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VERAVera Therapeutics Inc
11/05/202322:41Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VERAVera Therapeutics Inc
13/04/202322:07Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VERAVera Therapeutics Inc
30/03/202322:25Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VERAVera Therapeutics Inc
30/03/202322:24Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VERAVera Therapeutics Inc
28/03/202322:34Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VERAVera Therapeutics Inc
16/02/202322:07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VERAVera Therapeutics Inc
14/02/202323:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VERAVera Therapeutics Inc
06/02/202322:05GlobeNewswire Inc.Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common StockNASDAQ:VERAVera Therapeutics Inc
02/02/202303:51GlobeNewswire Inc.Vera Therapeutics Announces Pricing of Public Offering of Class A Common StockNASDAQ:VERAVera Therapeutics Inc
01/02/202322:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VERAVera Therapeutics Inc
01/02/202322:01GlobeNewswire Inc.Vera Therapeutics Announces Commencement of Public Offering of Class A Common StockNASDAQ:VERAVera Therapeutics Inc
21/11/202216:15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Vera Therapeutics (VERA)NASDAQ:VERAVera Therapeutics Inc
18/11/202213:05TipRanksVera Therapeutics (VERA) Receives a Buy from J.P. MorganNASDAQ:VERAVera Therapeutics Inc
22/08/202212:30TipRanksAnalysts’ Top Healthcare Picks: Vera Therapeutics (VERA), ADC Therapeutics (ADCT)NASDAQ:VERAVera Therapeutics Inc
06/07/202213:30GlobeNewswire Inc.Vera Therapeutics Completes Patient Enrollment in Phase 2b ORIGIN Clinical Trial of Atacicept for the Treatment of IgA NephropathyNASDAQ:VERAVera Therapeutics Inc
04/06/202220:30GlobeNewswire Inc.Vera Therapeutics Reports Positive Interim Phase 2 Data Showing MAU868 Has Significant BK Antiviral Activity in Kidney Transplant PatientsNASDAQ:VERAVera Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VERA

La tua Cronologia

LSE
ZT11
Princ.b.s.28
BIT
UC3FAA
Unicredit Bank
BIT
UIJ521
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci